Fundraising FoxMicrobion
Bozeman, US · Delaware corporation · 1 known investors
Find your way into Microbion
Sign up to see every warm intro you have to Microbion
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Microbion team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Microbion develops therapeutics targeting biofilm-associated infections, with a lead candidate (Pravibismane) in clinical development for diabetic foot ulcer, orthopedic implant, and respiratory infections. The company operates in the biotech industry.
Founders & leadership
FK
Frank KerinsExecutive
BB
Brett BakerFounder, President & Chief Innovation Officer
Board
RM
Rodger MayBoard director
JC
Jared CarneyBoard director
SS
Steven SchellongBoard director
JL
Julia LevyBoard director
JH
Jason HarmonBoard director
Investors · 1
Quark Venture Inc.✓ confirmed by MicrobionVancouver
How we know: the company's own site · press coverage · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$43.1M disclosed across 3 rounds · 2014–2021
▶$11.9MraisedJul 2021 · 18 investors · PharmaceuticalsRule 506(b)
▶$11.9MraisedJul 2021 · 18 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Brett BakerExecutive Officer, Director
- Robert GillamDirector
- Jarret ShaDirector
- Jason HarmonDirector
- Karim LaljiDirector
- Kaley WilsonDirector
- Offering amount
- $13.4M
- Amount sold
- $11.9M
- First sale
- Jan 2021
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$25.4MraisedJan 2017 · 11 investors · BiotechnologyRule 506(b)
▶$25.4MraisedJan 2017 · 11 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Karim LaljiDirector
- Jason HarmonDirector
- Zafrira AvnurDirector
- Roger KuypersDirector
- Brett BakerExecutive Officer, Director
- Offering amount
- $51.3M
- Amount sold
- $25.4M
- First sale
- Dec 2016
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$5.9MraisedJan 2016 · 33 investors · BiotechnologyRule 506(b)
▶$5.9MraisedJan 2016 · 33 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Rodger MayDirector
- Jared CarneyDirector
- Steven SchellongDirector
- Karim LaljiExecutive Officer, Director
- Julia LevyDirector
- Jason HarmonDirector
- Brett BakerExecutive Officer, Director
- Frank KerinsExecutive Officer
- Offering amount
- $8.5M
- Amount sold
- $5.9M
- First sale
- Jan 2014
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Related companies · 3
Vividion TherapeuticsVividion Therapeutics develops small molecule therapeutics using a covalent-first chemoproteomics approach to identify and target previously undruggable proteins. The company operates across the full drug development spectrum from discovery to clinical development.
Esperion TherapeuticsBiopharma developing HDL-C regulating therapies; listed 2000.
bioBIO is the world's largest advocacy association representing biotechnology companies and research institutions across the United States and 30+ other nations. The organization facilitates industry networking through events, conferences, and partnering software while providing cost-savings programs and advocacy services for member companies.
Companies working in the same space as Microbion.
In the news
Frequently asked questions
- What does Microbion do?
- Microbion develops therapeutics targeting biofilm-associated infections, with a lead candidate (Pravibismane) in clinical development for diabetic foot ulcer, orthopedic implant, and respiratory infections. The company operates in the biotech industry.
- Who are Microbion's investors?
- Microbion's investors include Quark Venture Inc..
- How much funding has Microbion raised?
- Microbion has disclosed $43.1M raised across 3 rounds.
- Where is Microbion headquartered?
- Microbion is headquartered in Bozeman, US.